The spread of COVID-19 has presented the global healthcare and life sciences sectors with unprecedented challenges. At the same time, it has underscored how quickly the industry can pivot to boost capacity in critical areas and support significant rapid changes in demand for technology and devices around the world.

As well as the immediate pressures on governments and healthcare services, COVID-19 has also unearthed important questions for the future of medical devices and technology. For instance, in years to come, which medical devices will be regarded as ‘critical’? How will this affect the supply chains of the companies producing these devices? What government regulations and requirements will exist for safeguarding domestic populations?

The opportunities and challenges that we discuss in this paper are designed to provide a rough guide to success in the medical technology space. At Alvarez & Marsal, we are leveraging our specialisms in operational transformation, transaction advisory and supply chain to guide leading enterprises through difficult times. We look forward to observing and contributing as the medical technology sector continues to develop.

Click here to read the article.